Published in Vasc Med on May 19, 2010
L-Arginine in the Treatment of Peripheral Arterial Disease | NCT00284076
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population. PLoS One (2015) 3.46
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation (2013) 3.45
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators? Arterioscler Thromb Vasc Biol (2012) 1.19
DDAH says NO to ADMA. Arterioscler Thromb Vasc Biol (2011) 1.00
Global trends, potential mechanisms and early detection of organ damage in SLE. Nat Rev Rheumatol (2012) 0.97
Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies. J Am Heart Assoc (2015) 0.94
Asymmetric dimethyarginine as marker and mediator in ischemic stroke. Int J Mol Sci (2012) 0.88
Proton pump inhibitors and vascular function: A prospective cross-over pilot study. Vasc Med (2015) 0.83
Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice. Am J Physiol Heart Circ Physiol (2014) 0.81
Association of lower extremity performance with cardiovascular and all-cause mortality in patients with peripheral artery disease: a systematic review and meta-analysis. J Am Heart Assoc (2014) 0.80
4-HNE increases intracellular ADMA levels in cultured HUVECs: evidence for miR-21-dependent mechanisms. PLoS One (2013) 0.78
Role of alpha-lipoic acid in the management of anemia in patients with chronic renal failure undergoing hemodialysis. Int J Nephrol Renovasc Dis (2013) 0.77
How May Proton Pump Inhibitors Impair Cardiovascular Health? Am J Cardiovasc Drugs (2016) 0.77
Characterization of a fluorescent probe for imaging nitric oxide. J Vasc Res (2013) 0.75
Mechanisms of Atherosclerosis: New Insights and Novel Therapeutic Approaches. Methodist Debakey Cardiovasc J (2015) 0.75
Proton-pump inhibitors: understanding the complications and risks. Nat Rev Gastroenterol Hepatol (2017) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA (2001) 13.65
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med (1986) 6.05
Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation (2007) 5.87
Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol (2007) 4.13
Medical treatment of peripheral arterial disease and claudication. N Engl J Med (2001) 3.92
Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med (2007) 3.28
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation (1998) 3.25
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA (2002) 3.20
Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation (1999) 2.77
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation (2002) 2.65
Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med (1997) 2.44
L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest (1992) 2.35
Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation (1998) 2.27
L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA (2006) 2.24
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation (1997) 2.20
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation (1999) 2.14
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation (2003) 2.12
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest (1992) 2.07
L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation (2007) 1.97
Asymmetrical dimethylarginine: the Uber marker? Circulation (2004) 1.91
ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke (2006) 1.88
Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet (2003) 1.84
Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation (2003) 1.84
The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol (1988) 1.75
Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation (2005) 1.75
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation (1995) 1.74
NO and angiogenesis. Atheroscler Suppl (2003) 1.64
Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation (2001) 1.63
Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med (2004) 1.41
Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol (2005) 1.32
Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide (1997) 1.31
Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arterioscler Thromb Vasc Biol (2006) 1.18
The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med (1994) 1.09
Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. Circulation (2005) 1.08
Comparison of arterial assessments in low and high vascular disease risk groups. Am J Hypertens (2004) 1.07
Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury. J Am Coll Cardiol (2007) 1.04
Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA). Vasc Med (2005) 0.98
Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis (2004) 0.97
Atherosclerosis-associated endothelial dysfunction. Z Kardiol (2000) 0.96
Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology. Circulation (1994) 0.93
Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes. Atherosclerosis (2006) 0.93
Suboptimal intensity of risk factor modification in PAD. Vasc Med (2005) 0.90
Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol (2005) 0.90
Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA Study. Eur J Cardiovasc Prev Rehabil (2007) 0.87
The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia. Eur J Vasc Endovasc Surg (1996) 0.87
A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease. Vasc Med (2005) 0.83
Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease. Prostaglandins Other Lipid Mediat (2006) 0.78
Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair. Cell (2008) 4.26
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation (2013) 3.45
Statins have biphasic effects on angiogenesis. Circulation (2002) 3.39
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA (2002) 3.20
Activation of innate immunity is required for efficient nuclear reprogramming. Cell (2012) 2.99
Type IV pilin structure and assembly: X-ray and EM analyses of Vibrio cholerae toxin-coregulated pilus and Pseudomonas aeruginosa PAK pilin. Mol Cell (2003) 2.78
Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation (2007) 2.72
Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res (2007) 2.71
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation (2002) 2.65
Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation (2003) 2.30
Boc is a receptor for sonic hedgehog in the guidance of commissural axons. Nature (2006) 2.29
Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation (2007) 2.21
A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest (2002) 2.19
Second hand smoke stimulates tumor angiogenesis and growth. Cancer Cell (2003) 2.17
Nitric oxide inhibition as a mechanism for blood pressure increase during salt loading in normotensive postmenopausal women. J Hypertens (2003) 2.04
Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation (2003) 1.98
L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation (2007) 1.97
Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol (2011) 1.93
Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis. Nephrol Dial Transplant (2006) 1.90
Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne Syndrome. Mol Cell (2005) 1.89
ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke (2006) 1.88
Alternative ankle-brachial index method identifies additional at-risk individuals. J Am Coll Cardiol (2013) 1.86
Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation (2003) 1.84
Murine model of hindlimb ischemia. J Vis Exp (2009) 1.82
Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol (2009) 1.77
Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat Med (2012) 1.74
Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol (2012) 1.71
Endothelial progenitor cells participate in nicotine-mediated angiogenesis. J Am Coll Cardiol (2006) 1.70
Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia. Circulation (2004) 1.69
Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation (2010) 1.67
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation (2004) 1.62
Conversion of human fibroblasts to functional endothelial cells by defined factors. Arterioscler Thromb Vasc Biol (2013) 1.61
Nitric oxide and angiogenesis. Circulation (2002) 1.56
Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. FASEB J (2006) 1.54
Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol (2002) 1.54
Embryonic stem cell-derived endothelial cells for treatment of hindlimb ischemia. J Vis Exp (2009) 1.49
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation (2003) 1.49
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation (2006) 1.46
Nicotine promotes arteriogenesis. J Am Coll Cardiol (2003) 1.42
Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol (2010) 1.42
Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay. Clin Chem Lab Med (2004) 1.41
Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation (2005) 1.35
Limited gene expression variation in human embryonic stem cell and induced pluripotent stem cell-derived endothelial cells. Stem Cells (2013) 1.29
Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol (2011) 1.27
Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet (2011) 1.26
Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury. Cardiovasc Res (2007) 1.25
Limb hemodynamics are not predictive of functional capacity in patients with PAD. Vasc Med (2006) 1.22
Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity. Am J Transl Res (2013) 1.18
The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol (2010) 1.18
Low lifetime recreational activity is a risk factor for peripheral arterial disease. J Vasc Surg (2011) 1.18
Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol (2008) 1.16
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation (2006) 1.11
Exercise capacity is the strongest predictor of mortality in patients with peripheral arterial disease. J Vasc Surg (2012) 1.10
A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration. Arterioscler Thromb Vasc Biol (2006) 1.10
Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol (2007) 1.09
Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease. Circulation (2005) 1.08
Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation. Stroke (2007) 1.07
Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler Thromb Vasc Biol (2002) 1.06
Mecamylamine suppresses Basal and nicotine-stimulated choroidal neovascularization. Invest Ophthalmol Vis Sci (2008) 1.06
Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury. J Am Coll Cardiol (2007) 1.04
Genetics of peripheral artery disease. Circulation (2012) 1.03
Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance. Cardiovasc Diabetol (2011) 1.03
Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization. Vasc Med (2010) 1.03
Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography. Am J Cardiol (2013) 1.02
A biomarker panel for peripheral arterial disease. Vasc Med (2008) 1.01
Ultrahigh resolution and full-length pilin structures with insights for filament assembly, pathogenic functions, and vaccine potential. J Biol Chem (2011) 1.01
Developmental endothelial locus-1 (Del-1), a novel angiogenic protein: its role in ischemia. Circulation (2004) 1.01
Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2α) impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal (2011) 1.01
Psychophysiological and cortisol responses to psychological stress in depressed and nondepressed older men and women with elevated cardiovascular disease risk. Psychosom Med (2006) 1.00
DDAH says NO to ADMA. Arterioscler Thromb Vasc Biol (2011) 1.00
Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol (2008) 0.97
nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis. PLoS One (2009) 0.97
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med (2005) 0.97
Cell-free production of transducible transcription factors for nuclear reprogramming. Biotechnol Bioeng (2009) 0.96
Conserved structural chemistry for incision activity in structurally non-homologous apurinic/apyrimidinic endonuclease APE1 and endonuclease IV DNA repair enzymes. J Biol Chem (2013) 0.96
Does leptin cause vascular disease? Circulation (2002) 0.96
Amyotrophic lateral sclerosis. Adv Exp Med Biol (2010) 0.96
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Circulation (2013) 0.95
Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis. Gene Ther (2004) 0.95
State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association. Circ Res (2015) 0.94
Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor. J Cell Biochem (2009) 0.94
Walking impairment questionnaire improves mortality risk prediction models in a high-risk cohort independent of peripheral arterial disease status. Circ Cardiovasc Qual Outcomes (2013) 0.94
Endothelial cells derived from nuclear reprogramming. Circ Res (2012) 0.93
Homocysteine impairs coronary microvascular dilator function in humans. J Am Coll Cardiol (2002) 0.93
PPARδ activation protects endothelial function in diabetic mice. Diabetes (2012) 0.92
Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. J Clin Microbiol (2007) 0.92
Task force 11: training in vascular medicine and peripheral vascular catheter-based interventions endorsed by the Society for Cardiovascular Angiography and Interventions and the Society for Vascular Medicine. J Am Coll Cardiol (2008) 0.92
Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor. Vasc Med (2005) 0.91
Role of nitric oxide signaling in endothelial differentiation of embryonic stem cells. Stem Cells Dev (2010) 0.91
Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia. Circ Res (2009) 0.91
Development of pluripotent stem cells for vascular therapy. Vascul Pharmacol (2012) 0.90
The modulation of endothelial cell morphology, function, and survival using anisotropic nanofibrillar collagen scaffolds. Biomaterials (2013) 0.90
Suboptimal intensity of risk factor modification in PAD. Vasc Med (2005) 0.90
Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8. Proc Natl Acad Sci U S A (2014) 0.90
Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase. Atheroscler Suppl (2003) 0.90
Aligned nanofibrillar collagen regulates endothelial organization and migration. Regen Med (2012) 0.89
Concurrent generation of functional smooth muscle and endothelial cells via a vascular progenitor. Stem Cells Transl Med (2013) 0.89